CLS: Market approval in Singapore - Redeye - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

CLS: Market approval in Singapore - Redeye

{newsItem.title}

Redeye endorses CLS’ market approval for its TRANBERG portfolio in Singapore. The approval enables CLS to initiate the commercialization process in the Singapore market and is the first step towards a broader expansion in the Asia-Pacific region. We will assess how this milestone may change our forecasts.

Länk till analysen i sin helhet: https://www.redeye.se/research/970886/cls-market-approval-in-singapore?utm_source=finwire&utm_medium=RSS

Nyheter om Clinical Laserthermia

Läses av andra just nu

Om aktien Clinical Laserthermia

Senaste nytt